Navigation Links
EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available in U.S. Pharmacies for Patients with Hypertension
Date:2/6/2012

hypertension patients are not at their blood pressure targets, putting them at increased cardiovascular risk," said Douglas Cole, president, Takeda Pharmaceuticals U.S.A., Inc. "We're pleased to bring EDARBYCLOR to market and expand the EDARBI family of products to help appropriate patients with hypertension work towards reaching their blood pressure goals."

About Hypertension
Hypertension, or high blood pressure, is a chronic medical condition in which blood pressure is elevated to levels of 140 mm Hg or greater systolic and/or 90 mm Hg or greater diastolic. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mm Hg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Control of high blood pressure should be part of comprehensive cardiovascular risk management including, as appropriate, lipid control, management of diabetes, prevention of blood clots, smoking cessation, exercise and limited sodium intake.

Hypertension impacts approximately 76 million Americans, or nearly one in three adults. It is estimated that nearly one billion people are affected by hypertension worldwide, and this figure is predicted to increase to 1.5 billion by 2025. Hypertension typically has no symptoms. Adults of all ages and backgrounds can develop hypertension; however, the risk of developing the condition increases with age, with more than half of people over age 60 affected. Hypertension is also costly to the nation's health care system. The American Heart Association recently estimated that direct and indirect expenses associated with hypertension cost the nation more than $73 billion in 2009.

About EDARBI and EDARBYCLOR
EDARBI (azilsartan medoxomil) is an angiotensin II receptor blocker (ARB) developed by Takeda for the treatment of hypertension to lower blood pressure in adults. EDARBI lowers blood pressure b
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
2. EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension
3. FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
4. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
5. New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
6. New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
7. NHS Makes £200 Non-Drug Hypertension Treatment Device Available on Prescription
8. PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
9. Nearly 9 Million Kaiser Permanente Health Records Securely Available on Mobile Devices
10. Edgemont - New Fluoxetine Tablets, 60 mg Now Available
11. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... FRANCISCO, Calif. , May 22, 2013 ... announced the clinical advancement of three programs in development. ... of a JAK/SYK inhibitor, R348, being developed by Rigel ... two programs are aimed at oncology targets and are ... inhibitor under development by BerGenBio AS (BerGenBio) and a ...
(Date:5/22/2013)... May 22, 2013 WomanCare Global recently ... with an extensive training initiative attended by 90 ... http://photos.prnewswire.com/prnh/20130522/DC18844 ) (Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO ) ... a highly effective subdermal implant composed of two ... levonorgestrel (a synthetic form of the hormone progestin). ...
(Date:5/21/2013)... 2013  NxStage Medical, Inc. (Nasdaq: NXTM ... announced that it has entered into new agreements covering ... to DaVita, the kidney care division of DaVita Healthcare Partners ... For the use of products for home hemodialysis ... has executed a second amended and restated National Service ...
Breaking Medicine Technology:Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4WomanCare Global launches Simplant, Long-acting Reversible Contraception, in Chile 2NxStage Announces New Agreements with DaVita 2
... /PRNewswire-USNewswire/ -- The Barbara,Ann Karmanos Cancer Institute's Philip ... oncology, presented the outcome,of one of the largest ... America and chaired an education session about the,future ... of,Clinical Oncology (ASCO) annual meeting in Chicago, IL. ...
... 2007 - First-in-human results for,IMC-A12, a monoclonal antibody ... to IGF-1R (insulin-like,growth factor type 1 receptor), were ... of Clinical Oncology in Chicago.,The IGF-IR is expressed ... transmits signals that lead to tumor cell growth ...
Cached Medicine Technology:Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 2Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 3
(Date:5/22/2013)... 22, 2013 Following the success of ... franchise Fit Body Boot Camp Kincardine has announced ... Meltdown Challenge starting on June 3rd at its ... Durham Street, Kincardine, Ontario.     , Fit Body Boot Camp’s ... motivate local community residents to lose a total of ...
(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 ... and management solutions for social enterprise collaboration platforms, ... a consulting firm based in Chicago, Ill. The ... their products and provide best-in-class solutions for SharePoint ... improve collaboration. , AvePoint’s DocAve Software Platform ...
(Date:5/22/2013)... May 22, 2013 Poor adherence to ... not only medical complications and death (some 125,000 deaths ... non-adherence), but increased health-care costs. It’s been estimated that ... are related to poor medication adherence — a reality ... annually. , Indeed, so dire is the degree of ...
(Date:5/22/2013)... 2013 Athletic-Minded Traveler LLC, a ... released today its 2013 U.S. Business Hotel “Fit ... the company’s recommendation after ongoing research of over ... by the editorial staff. Selection criteria included ... court, etc.), in-room workout choices, healthy food offerings, ...
(Date:5/21/2013)... 22, 2013 Swimsuit season is almost here. ... ® products has begun with a 35% discount. , Cellulite ... Many women get the dreaded cellulite even if they are ... skin where they have been stored as toxic lymph and ... easy fixes, a specific program that works to dissolve the ...
Breaking Medicine News(10 mins):Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2
... to improve care and quality of ... SAN ANTONIO, Texas, Oct. 27 In ... begins November 15th, Care,Improvement Plus today announced the ... for chronically ill Medicare beneficiaries in Texas,including new ...
... less likely to get venous thromboembolism , , MONDAY, Oct. ... used to lower cholesterol may have a future in ... and other solid-organ cancers. , Research from scientists at ... cancer patients taking statins had a lower incidence of ...
... which typically helps a person heal from an injury, ... (IPF) to get worse, researchers at the National Institute ... National Institutes of Health (NIH), and their collaborators have ... why some patients with IPF get more short of ...
... Department of Medical Oncology at Jefferson Medical College of ... for the Kimmel Cancer Center at Jefferson, was recently ... Wellness of You, a local nonprofit health education and ... award recognizes health professionals who are committed to making ...
... added benefits to improve care and quality ... conditions -, COLUMBIA, S.C., Oct. 27 ... which begins November 15th, Care,Improvement Plus today announced ... offerings for chronically ill Medicare beneficiaries in South,Carolina, ...
... - Special Needs Plan focuses on added benefits ... for Medicare beneficiaries with chronic health conditions -, ... for the upcoming,Medicare annual enrollment period which begins ... of its 2009 Special Needs Plan,(SNP) offerings for ...
Cached Medicine News:Health News:Care Improvement Plus Launches 2009 Benefits in Texas 2Health News:Statins Lower Risk of Clots in Cancer Patients 2Health News:Healing process found to backfire in lung patients 2Health News:Jefferson doctor receives Tree of Life award 2Health News:Jefferson doctor receives Tree of Life award 3Health News:Care Improvement Plus Launches 2009 Benefits in South Carolina 2Health News:Care Improvement Plus Launches 2009 Benefits in Missouri 2
The Storz Protege is an anterior segment unit only....
The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....
Compact ultrasonic phacoemulsification system....
... Precisionist workstation is a unique combination ... allowing infinite flexibility for modular hardware ... the demands of changing cataract surgical ... concept in ophthalmic surgical platforms providing ...
Medicine Products: